[1] Spinal cord injury facts and figures at a glance. J Spinal Cord Med. 2013;36(6):715-716.[2] Ducker TB, Spengler DM, Balderston R, et al. Spinal cord injury and glucocortical steroid therapy: good news and bad. J Spinal Disord. 1990;3(4):433. [3] Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008;209(2): 378-388.[4] Bramlett HM, Dietrich WD. Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog Brain Res. 2007;161:125-141. [5] Benucci M, Li G F, Meacci F, et al. Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins. Biologics. 2015;9:7-12. [6] Nockels R, Young W. Pharmacologic strategies in the treatment of experimental spinal cord injury. J Neurotrauma. 1992;9 Suppl 1:S211-S217.[7] Yune TY, Chang MJ, Kim SJ, et al. Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats. J Neurotrauma. 2003; 20(2):207-219. [8] Wang CX, Nuttin B, Heremans H, et al. Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J Neuroimmunol. 1996;69(1-2):151-156. [9] Chen K B, Uchida K, Nakajima H, et al. Tumor necrosis factor-alpha antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury. Spine (Phila Pa 1976). 2011;36(17):1350-1358. [10] Lebedev SV, Karasev AV, Chekhonin VP, et al. Study of the efficiency of transplantation of human neural stem cells to rats with spinal trauma: the use of functional load tests and BBB test. Bull Exp Biol Med. 2010;149(3):377-382.[11] Sobani ZA, Quadri SA, Enam SA. Stem cells for spinal cord regeneration: current status. Surg Neurol Int. 2010;1:93.[12] Kan EM, Ling EA, Lu J. Stem cell therapy for spinal cord injury. Curr Med Chem. 2010;17(36):4492-4510.[13] Takahashi Y, Tsuji O, Kumagai G, et al. Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice. Cell Transplant. 2011;20(5):727-739.[14] Sakaguchi M, Okano H. Neural stem cells, adult neurogenesis, and galectin-1: from bench to bedside. Dev Neurobiol. 2012;72(7):1059-1067.[15] Ekshyyan O. Apoptosis in acute and chronic neurological disorders. Front Biosci. 2004;9:1567.[16] Wang JM, Zeng YS, Wu JL, et al. Cograft of neural stem cells and schwann cells overexpressing TrkC and neurotrophin-3 respectively after rat spinal cord transection. Biomaterials. 2011,32(30):7454-7468.[17] Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol. 1996;139(2):244-256.[18] Wang L, Wei FX, Cen JS, et al. Early administration of tumor necrosis factor-alpha antagonist promotes survival of transplanted neural stem cells and axon myelination after spinal cord injury in rats. Brain Res. 2014;1575:87-100.[19] Cen J, Wu H, Wang J, et al. Local injection of lentivirus encoding LINGO-1-shRNA promotes functional recovery in rats with complete spinal cord transection. Spine (Phila Pa 1976). 2013;38(19):1632-1639.[20] Guo J, Zeng Y, Li H, et al. Cotransplant of neural stem cells and NT-3 gene modified Schwann cells promote the recovery of transected spinal cord injury. Spinal Cord. 2007;45(1): 15-24.[21] Ferguson AR, Christensen RN, Gensel JC, et al. Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J Neurosci. 2008;28(44):11391-11400.[22] Beattie MS, Hermann GE, Rogers RC, et al. Cell death in models of spinal cord injury. Prog Brain Res. 2002;137:37-47.[23] Novikova LN, Novikov LN, Kellerth JO. Differential effects of neurotrophins on neuronal survival and axonal regeneration after spinal cord injury in adult rats. J Comp Neurol. 2002; 452(3):255-263.[24] Wang JM, Zeng YS, Liu RY, et al. Recombinant adenovirus vector-mediated functional expression of neurotropin-3 receptor (TrkC) in neural stem cells. Exp Neurol. 2007; 203(1):123-127.[25] Xiong Y, Zhu JX, Fang ZY, et al. Coseeded Schwann cells myelinate neurites from differentiated neural stem cells in neurotrophin-3-loaded PLGA carriers. Int J Nanomedi. 2012;7: 1977-1989.[26] Mohler KM, Torrance DS, Smith CA, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol. 1993; 151(3):1548-1561.[27] Spencer-Green G. Etanercept (Enbrel): update on therapeutic use. Ann Rheum Dis. 2000;59 Suppl 1:i46-i49.[28] Roozbehi A, Joghataie MT, Mehdizadeh M, et al. The effects of cyclosporin-A on functional outcome and axonal regrowth following spinal cord injury in adult rats. Acta Med Iran. 2012; 50(4):226-232.[29] Sevc J, Goldberg D, van Gorp S, et al. Effective long-term immunosuppression in rats by subcutaneously implanted sustained-release tacrolimus pellet: effect on spinally grafted human neural precursor survival. Exp Neurol. 2013;248: 85-99.[30] Rabchevsky AG, Fugaccia I, Sullivan PG, et al. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J Neurotrauma. 2001;18(5):513-522.[31] Alessiani M, Cillo U, Fung JJ, et al. Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc. 1993; 25(1 Pt 1):628-634.[32] Hesselink DA, Bouamar R, Elens L, et al. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2014;53(2):123-139.[33] Genovese T, Mazzon E, Crisafulli C, et al. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther. 2006;316(3):1006-1016.[34] Takahashi Y, Tsuji O, Kumagai G, et al. Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice. Cell Transplant. 2011;20(5): 727-739.[35] Kamei N, Tanaka N, Oishi Y, et al. BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures. Spine (Phila Pa 1976). 2007;32(12):1272-1278.[36] Lai BQ, Wang JM, Duan JJ, et al. The integration of NSC-derived and host neural networks after rat spinal cord transection. Biomaterials. 2013;34(12):2888-2901.[37] 谢强,王飞,周国平,等.腺病毒介导脑源性神经营养因子与脑出血模型大鼠内源性神经干细胞的分化[J].中国组织工程研究,2016, 20(27):4029-4035. |